Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

James Comprehensive Cancer Center

2 abstracts

Abstract
UP-NEXT (GOG-3049/ENGOT-Ov71-NSGO-CTU): A study of upitifamab rilsodotin (UpRi), a NaPi2b-directed antibody drug conjugate (ADC), in platinum-sensitive recurrent ovarian cancer.
Org: Stephenson Cancer Center/University of Oklahoma Health Sciences Center and Sarah Cannon Research Institute, Sarah Cannon Research Institute/Tennessee Oncology, Kliniken Essen-Mitte, Evangelische Huyssens-Stiftung/Knappschaft GmbH, The Ohio State University - James Cancer Hospital,
Abstract
Predictors of long-term progression-free survival (PFS) in niraparib-treated patients (pts) from the PRIMA/ENGOT-OV26/GOG-3012 study.
Org: Medical University of South Carolina Hollings Cancer Center, Institut Català d’Oncologia L’Hospitalet de Llobregat, Hospital Duran i Reynals, IDIBELL, Grupo Español de Investigación en Cáncer de Ovario (GEICO),